A phase 1b study to evaluate the safety and antitumor activity of MEDI4736 in combination with tremelimumab in patients with advanced NSCLC Meeting Abstract
| Authors: | Goldberg, S. B.; Balmanoukian, A.; Chaft, J.; Rizvi, N.; Sanborn, R. E.; Rebelatto, M. C.; Narwal, R.; Robbins, P. B.; Gu, Y.; Karakunnel, J. J.; Antonia, S. |
| Abstract Title: | A phase 1b study to evaluate the safety and antitumor activity of MEDI4736 in combination with tremelimumab in patients with advanced NSCLC |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S627 |
| Language: | English |
| ACCESSION: | WOS:000361887403044 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31727-0 |
| Notes: | Meeting Abstract: 3086 -- Source: Wos |
